Laos vs Turkey: The number of people with susceptibility test result for rifampicin
Laos
3,796
in 2021
Turkey
3,654
in 2021
Laos rank
36th
Turkey rank
37th
The number of people with susceptibility test result for rifampicin over time
- Laos
- Turkey
How they compare
Laos currently reports 3,796 against 3,654 in Turkey, a difference of 142.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Turkey ahead.
Laos ranks 36th and Turkey ranks 37th of 155 countries.
Across the 2 decades both report, Laos averaged higher in 1 and Turkey in 1.
Head to head by decade
| Decade | Laos | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,477 | 4,810 | 2,333 | Turkey |
| 2020s | 3,803 | 3,716 | 87.5 | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Laos or Turkey?
- Laos, at 3,796 against 3,654 in Turkey as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Laos and Turkey?
- 142, with Laos ahead.
- How many years of comparable data are there for Laos and Turkey?
- 5 years are reported by both, from 2017 to 2021.
- How do Laos and Turkey rank globally for the number of people with susceptibility test result for rifampicin?
- Laos ranks 36th and Turkey ranks 37th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.